Vanderbilt Vaccine Center

Long antibodies better against HIV

Understanding how antibodies with long “loops” form may be important for HIV vaccine development.

Dengue antibodies give vaccine leads

New information may help speed development of a vaccine or treatment for dengue fever.

Targeting post-transplant diabetes

Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes.

On the tail of RSV infection mechanism

New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly.

Richard Powell

Digestive disease research bolstered by grant renewal

The Vanderbilt Digestive Disease Research Center celebrates its 10th anniversary this year with a second five-year renewal of its federal research grant.

antibodies

Diversity key in antibody repertoire

Antibodies to the 2009 H1N1 influenza strain reveal new insights into how antibody diversity forms and functions, with possible implications for designing flu vaccines.

1 11 12 13 14